Anti-HIF-1 alpha 抗体 [EPR16897]
Anti-HIF-1 alpha antibody [EPR16897]
- RabMAb
- Advanced Validation
- Recombinant
- KO Validated
- 了解详情
4
(9 Reviews)
|
(364 Publications)
Anti-HIF-1 alpha antibody [EPR16897] (ab179483) is a rabbit monoclonal antibody detecting HIF-1 alpha in Western Blot, IP, ICC/IF, ChIP. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 190 publications
查看别名
BHLHE78, MOP1, PASD8, HIF1A, Hypoxia-inducible factor 1-alpha, HIF-1-alpha, HIF1-alpha, ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, Class E basic helix-loop-helix protein 78, Member of PAS protein 1, PAS domain-containing protein 8, bHLHe78
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling HIF-1-alpha with ab179483 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing nuclear staining in HeLa cells treated with DFO (1 mM, 24 h). The nuclear counter stain is DAPI (blue). Tubulin is detected with ab195889 (anti-alpha Tubulin mouse mAb) (Alexa Fluor® 594) at 1/200 dilution (red).
- IP
Lab
Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
ab179483 at 1/30 dilution immunoprecipitating HIF-1 alpha in HeLa (human cervix adenocarcinoma epithelial cell) treated with 500 µM CoCl2 for 24 hours whole cell lysate. Western blot was performed from the immunoprecipitate using ab179483 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution. Lane 1 : HeLa (human cervix adenocarcinoma epithelial cell) treated with 500 µM CoCl2 for 24 hours whole cell lysate 10 µg Lane 2 : ab179483 IP in HeLa (human cervix adenocarcinoma epithelial cell) treated with 500 µM CoCl2 for 24 hours whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab179483 in HeLa treated with 500 µM CoCl2 for 24 hours whole cell lysate Blocking/Dilution buffer : 5% NFDM/TBST. Exposure time : 8 seconds.
Lane 2:
Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 1/30 dilution
Lane 2:
Immunoprecipitation - Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide free (<a href='/products/primary-antibodies/hif-1-alpha-antibody-epr16897-bsa-and-azide-free-ab221610'>ab221610</a>)
All lanes:
HeLa (human cervix adenocarcinoma epithelial cell) treated with 500 µM CoCl2 for 24 hours whole cell lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 110 kDa
false
Exposure time: 8s
- ChIP-seq
Supplier Data
ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.
- ChIP-seq
Supplier Data
ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.
- ChIP-seq
Supplier Data
ChIP-sequencing - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
Chromatin was prepared from HeLa cells treated with CoCl2 (350μM 20h+4h) add MG-132(10µM 4h). Cells were fixed with 1% formaldehyde for 10 minutes. ChIP was performed with 107 cells and 8 µg of ab308433 [EPR16897-145] or ab179483 [EPR16897]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. The Input control is also shown.
- WB
Supplier Data
Western blot - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 17906695).
Lysates were freshly made and used immediately to minimize protein degradation.
In Western Blot, Anti HIF-1 alpha antibody [EPR16897-101] (ab179483) is applied at 1/1000 dilution to prove the DFO induction is successful.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-CITED2 antibody [EPR27399-62] (<a href='/products/primary-antibodies/cited2-antibody-epr27399-62-ab314757'>ab314757</a>) at 1/1000 dilution
Lane 1:
Untreated HT-1080 (human fibrosarcoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HT-1080 treated with 0.5 mM DFO for 24 hours whole cell lysate at 20 µg
Lane 3:
HT-1080 treated with 0.5 mM DFO for 24 hours, then added 10uM MG-132 for 4 hours, whole cell lysate at 20 µg
Lane 4:
HT-1080 treated with 10uM MG-132 for 4 hours, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 30 kDa,36 kDa
false
Exposure time: 37s
- WB
Lab
Western blot - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
Lysates were freshly made and used immediately to minimise protein degradation.
Lanes 1 - 4:
Western blot - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 1/1000 dilution
Lanes 1 - 4:
Western blot - Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide free (<a href='/products/primary-antibodies/hif-1-alpha-antibody-epr16897-bsa-and-azide-free-ab221610'>ab221610</a>)
Lane 1:
Untreated HT-1080 (human fibrosarcoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HT-1080 treated with 0.5 mM DFO for 24 hours whole cell lysate at 20 µg
Lane 3:
HT-1080 treated with 0.5 mM DFO for 24 hours, then added 10uM MG-132 for 4 hours, whole cell lysate at 20 µg
Lane 4:
HT-1080 treated with 10uM MG-132 for 4 hours, whole cell lysate at 20 µg
Observed band size: 50-110 kDa
false
Exposure time: 10s
- WB
Lab
Western blot - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
Lanes 1 - 6 : Merged signal (red and green). Green - ab179483 observed at 105 kDa. Red - loading control, ab24834, observed at 50 kDa.
ab179483 was shown to specifically react with HIF-1 alpha in wild-type HAP1 treated DMOG (0.5mM 18hr) cells as signal was lost in HAP1 knockout treated DMOG (0.5 mM 18hr) knockout cells. Wild-type and HAP1 knockout samples were subjected to SDS-PAGE. ab179483 and ab24834 (Mouse anti-Histone H3 loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 40 µg
Lane 2:
Wild type HAP1 treated with DMOG (0.5mM 18hr) whole cell lysate at 40 µg
Lane 3:
HIF1A knockout HAP1 whole cell lysate at 40 µg
Lane 4:
HIF1A knockout HAP1 treated with DMOG (0.5mM 18hr) whole cell lysate at 40 µg
Lane 5:
HeLa whole cell lysate at 40 µg
Lane 6:
HeLa treated with DMOG (0.5mM 18hr) whole cell lysate at 40 µg
Predicted band size: 92 kDa
Observed band size: 105 kDa
false
- WB
Lab
Western blot - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
HIF-1-alpha is constantly synthesized but rapidly degraded under normoxic conditions, whereas reduced oxygen concentration results in stabilization of HIF-1-alpha. (PMID : 15104534)
Exposure time : Lanes 1-4 : 10 seconds, Lanes 5-6 : 20 seconds
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 1/1000 dilution
Lanes 1 and 3:
Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa treated with 0.5mM CoCl2 for 6h whole cell lysate at 20 µg
Lane 4:
HeLa treated with 0.5mM DFO for 24h whole cell lysate at 20 µg
Lane 5:
Untreated NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 6:
NIH/3T3 (Mouse embryonic fibroblast) treated with 0.1mM CoCl2 for 48h whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 50-110 kDa
false
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 HaCaT (Human keratinocyte cell line) cells (treated with 7ng/ml TGF-β for 1h) and 5 µg of ab40855 [EP784Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Lab
Western blot - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)
Blocking and diluting buffer : 5% NFDM/TBST.
The expression of HIF-1 alpha is induced by CoCl2 and maintained by MG-132 (PMID : 15836611).
All lanes:
Western blot - Anti-HIF-1 alpha antibody [EPR16897] (ab179483) at 0.163 µg/mL
Lane 1:
Untreated C6 (rat glial tumor glial cell), whole cell lysate at 10 µg
Lane 2:
C6 treated with 400 μM CoCl2 and 20 μM MG-132 (<a href='/products/biochemicals/mg-132-proteasome-inhibitor-ab141003'>ab141003</a>) for 4 hours at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 92 kDa
Observed band size: 110 kDa
false
Exposure time: 26s
不同偶联物与剂型 (3)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-HIF-1 alpha antibody [EPR16897]
-
Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-HIF-1 alpha antibody [EPR16897]
反应性数据
产品详情
Anti-HIF-1 alpha antibody [EPR16897] (ab179483) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ChIC/CUT&RUN-seq, ChIP,-seq ICC/IF, IP and WB.
First used in a scientific publication in 2016, it is highly cited in over 190 times in peer reviewed journals.
Abcam's high quality manufacturing and validation processes ensure Anti-HIF-1 alpha antibody [EPR16897] (ab179483) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Validated for both CUT&RUN and ChIP-seq, which are key applications to map protein-DNA interactions on a genome-wide scale using NGS.
The specificity of Anti-HIF-1 alpha antibody [EPR16897] (ab179483) has been confirmed by Western Blot testing in HIF-1 alpha knockout HAP1 cells making its performance in human, mouse and rat samples trusted by the scientific community.
Anti-HIF-1 alpha antibody [EPR16897] (ab179483) has 5 independent reviews from customers.
Anti-HIF-1 alpha antibody [EPR16897] (ab179483) specifically detects HIF-1 alpha (UniProt ID: Q16665; Molecular weight: 93kDa) and is sold in 100 µL and 1 mL selling sizes.
Conjugation-ready, carrier free format available for antibody clone EPR16897 - Anti-HIF-1 alpha antibody [EPR16897] - BSA and Azide freeab221610.
Antibody clone EPR16897 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647 (ab208419, ab208420).
HIF-1 or hypoxia inducible factor 1, is a transcription factor commonly referred to as a ""master regulator of the hypoxic response"" for its central role in the regulation of cellular adaptations to hypoxia. Hypoxia contributes to the pathophysiology of human disease, including myocardial and cerebral ischemia, cancer, pulmonary hypertension, congenital heart disease and chronic obstructive pulmonary disease. A highly specific HIF-1 alpha antibody, essential for studying hypoxia-inducible factors and oxygen homeostasis. This antibody is crucial in tumor hypoxia research, particularly in understanding cancer progression and angiogenesis. It is widely used in studies of metastasis and HIF-1 alpha inhibitors.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HIF-1 alpha regulates gene expression in response to hypoxic conditions in cells. It forms a complex with HIF-1 beta to activate transcription of various genes involved in energy metabolism angiogenesis and erythropoiesis. HIF-1 alpha enables cells to adapt to reduced oxygen availability allowing for cellular survival and function under stress. It plays an important role in promoting the expression of genes like VEGF and EPO which are important for vascular and red blood cell development respectively.
Pathways
HIF-1 alpha plays an integral role in the hypoxia signaling pathway and the glycolytic pathway. In the hypoxia signaling pathway HIF-1 alpha partners with VHL (Von Hippel-Lindau) protein that regulates its degradation under normal oxygen conditions. When oxygen levels drop HIF-1 alpha avoids degradation stabilizes and translocates into the nucleus to initiate transcription of hypoxia-responsive genes. The glycolytic pathway involvement highlights its function in adapting energy production under hypoxic conditions through collaboration with enzymes and transporters associated with glycolysis.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|zh
靶点信息
文献 (364)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:35547 PubMed41073566
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 54:492-508 PubMed40955375
2025
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 31:e70569 PubMed40927974
2025
Applications
Unspecified application
Species
Unspecified reactive species
Diabetology & metabolic syndrome 17:362 PubMed40883798
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceuticals (Basel, Switzerland) 18: PubMed40872544
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 23:950 PubMed40841904
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:7640 PubMed40819134
2025
Applications
Unspecified application
Species
Unspecified reactive species
Human cell 38:139 PubMed40775462
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:28627 PubMed40764760
2025
Applications
Unspecified application
Species
Unspecified reactive species
Current issues in molecular biology 47: PubMed40728968
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com